Showing results (61-70 of 152) with videos related to
Sort By:
Pageof 16
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 18, 2022
Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levelsCarlos Camara-Lemarroy, Luanne Metz, Jens Kuhle, et al.Nature Communications|February 12, 2020
Serum neurofilament light levels in normal aging and their association with morphologic brain changesMichael Khalil, Lukas Pirpamer, Edith Hofer, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2021
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosisBruce Ac Cree, Jeffrey A Cohen, Anthony T Reder, et al.Lancet (London, England)|November 4, 2011
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trialLudwig Kappos, David Li, Peter A Calabresi, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 27, 2013
A comparative study of CSF neurofilament light and heavy chain protein in MSJens Kuhle, Kim Plattner, Jonathan P Bestwick, et al.Journal of Neurology|February 10, 2021
Early life serum neurofilament dynamics predict neurodevelopmental outcome of preterm infantsKatharina Goeral, Annalisa Hauck, Andrew Atkinson, et al.Journal of Neuroinflammation|October 9, 2022
Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal modelTianrong Yeo, Halwan Bayuangga, Marcus Augusto-Oliveira, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 21, 2021
MRI Lesion State Modulates the Relationship Between Serum Neurofilament Light and Age in Multiple SclerosisMattia Rosso, Brian C Healy, Shrishti Saxena, et al.Annals of Neurology|May 18, 2017
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisGiulio Disanto, Christian Barro, Pascal Benkert, et al.BMJ Open|June 25, 2026
Evolution of blood biomarkers reflective of brain tissue damage and inflammation in the perioperative course of intracerebral haemorrhage evacuation in a phase II proof-of-concept trialTim Jonas Hallenberger, Eline Willemse, Catherine Brégère, et al.Pageof 16